Ying Yang 1, a master regulator of chronic inflammation in glioblastoma multiforme
Ying Yang 1,多形性胶质母细胞瘤慢性炎症的主要调节因子
基本信息
- 批准号:9515458
- 负责人:
- 金额:$ 19.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-15 至 2020-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAnti-inflammatoryAstrocytesBindingBioinformaticsCell LineCell NucleusCellsChronicComplexCytokine ActivationCytokine GeneCytoplasmDataDevelopmentEpigenetic ProcessFamilyFeedbackGene ActivationGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGlioblastomaGrowthHumanImmunocompetentIn VitroInfectionInflammationInflammatoryInjuryKnockout MiceLeadLentivirus VectorLinkLocationMalignant NeoplasmsMediatingModelingMolecularMonitorNecrosisNuclearNude MiceOncogenicPathologicPatientsPhenotypePlayPublishingRegulationRegulatory ElementRoleSamplingSurvival RateTNFRSF5 geneTestingTherapeutic InterventionTissuesTranscriptional ActivationYangYin-Yangantitumor effectchemokinecytokineexperimental studygenome-widehistone modificationhuman diseasein vivoin vivo Modelinhibitor/antagonistknock-downmembernovelp65preventprogramspromoterrecruitresponsetranscription factortranscriptome sequencingtumortumor growthtumor microenvironment
项目摘要
Although inflammation is normally short-lived and quickly resolves to limit tissue injury, chronic
inflammation is associated with several human cancer, including glioblastoma multiforme (GBM).
GBMs are very aggressive tumors with very low patient survival rates. These tumors are
characterized by necrosis and profound inflammation; with cytokines supporting GBM
progression. The mechanisms by which chronic inflammation develops and persists in GBM
regardless of multiple anti-inflammatory feedback loops remain elusive. One of the hallmarks of
ongoing acute inflammation is cytokine-driven temporal activation of the p65/p50 NF-κB
transcription factor, which drives expression of proinflammatory cytokines and chemokines.
However, targeting activation of p65/p50 NF-κB has thus far not been beneficial. Nevertheless,
p65/p50 NF-κB also initiates several feedback mechanisms, including induction of expression of
RelB, a unique member of the NF-κB family which forms complexes with p50 and suppresses
cytokine expression by mechanisms such as epigenetic silencing. This mechanism provide long-
lasting effects that limit inflammation.We found that although expression of RelB is similarly
induced in primary astrocytes and GBM, RelB suppresses cytokine expression in astrocytes, but
unexpectedly enhances their expression in GBM cells. Thus, the anti-inflammatory RelB-driven
feedback loop is converted into a feed-forward loop fueling chronic inflammation in GBM. We
further found that this differential regulation depends on a transcription factor Yin Yang 1 (YY1),
which is located in the cytoplasm of astrocytes but is exclusively present in the nuclei of GBM
cells. We also found that YY1 interacts with RelB and the complexes of RelB/YY1/p50 may be
responsible for the activation of cytokine expression in GBM cells. These preliminary data imply a
critical role of YY1 in GBM and support a mechanistic model which explains the development and
persistence of chronic inflammation associated with GBM. We propose that YY1 acts as a
molecular switch in GBM converting RelB-dependent epigenetic silencing into RelB/YY1/p50-
dependent transcriptional activation, which induces chronic inflammation and promotes GBM
aggressiveness. We will: 1. establish a molecular mechanism of YY1-dependent gene activation
and importance of YY1 in GBM in vitro, and 2. determine the role of YY1 in GBM development
and progression in vivo.
虽然炎症通常是短暂的并且很快就会消退以限制组织损伤,但慢性炎症
炎症与多种人类癌症有关,包括多形性胶质母细胞瘤(GBM)。
GBM 是一种侵袭性很强的肿瘤,患者存活率非常低。这些肿瘤是
以坏死和严重炎症为特征;含有支持 GBM 的细胞因子
进展。 GBM 中慢性炎症发生和持续的机制
尽管多重抗炎反馈回路仍然难以捉摸。的标志之一
持续的急性炎症是细胞因子驱动的 p65/p50 NF-κB 暂时激活
转录因子,驱动促炎细胞因子和趋化因子的表达。
然而,迄今为止,针对 p65/p50 NF-κB 的激活并没有带来好处。尽管如此,
p65/p50 NF-κB 还启动多种反馈机制,包括诱导
RelB,NF-κB 家族的独特成员,与 p50 形成复合物并抑制
通过表观遗传沉默等机制表达细胞因子。该机制提供了长期
限制炎症的持久效果。我们发现,尽管 RelB 的表达相似
在原代星形胶质细胞和 GBM 中诱导,RelB 抑制星形胶质细胞中的细胞因子表达,但
出乎意料地增强了它们在 GBM 细胞中的表达。因此,RelB 驱动的抗炎
反馈回路被转换为前馈回路,加剧 GBM 的慢性炎症。我们
进一步发现这种差异调节依赖于一个转录因子阴阳1(YY1),
位于星形胶质细胞的细胞质中,但仅存在于 GBM 的细胞核中
细胞。我们还发现YY1与RelB相互作用并且RelB/YY1/p50复合物可能是
负责 GBM 细胞中细胞因子表达的激活。这些初步数据意味着
YY1 在 GBM 中的关键作用并支持解释其发展和的机制模型
与 GBM 相关的慢性炎症持续存在。我们建议 YY1 作为
GBM 中的分子开关将 RelB 依赖性表观遗传沉默转化为 RelB/YY1/p50-
依赖性转录激活,诱导慢性炎症并促进 GBM
攻击性。我们将: 1.建立YY1依赖性基因激活的分子机制
以及YY1在体外GBM中的重要性,以及2.确定YY1在GBM发育中的作用
和体内进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOMASZ K KORDULA其他文献
TOMASZ K KORDULA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOMASZ K KORDULA', 18)}}的其他基金
Establishment of immunocompetent spontaneous glioma model to study glioma-associated astrocytes
建立免疫活性自发性胶质瘤模型以研究胶质瘤相关星形胶质细胞
- 批准号:
10212500 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
Regulation of astrocyte diversity in the cerebellum
小脑星形胶质细胞多样性的调节
- 批准号:
10659171 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
Regulation of astrocyte diversity in the cerebellum
小脑星形胶质细胞多样性的调节
- 批准号:
10454433 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
Regulation of astrocyte diversity in the cerebellum
小脑星形胶质细胞多样性的调节
- 批准号:
10278047 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Research Grant